Printer Friendly Version
Jon Turpin focuses his practice on intellectual property litigation. His practice focuses primarily on pharmaceutical patent actions under the Hatch-Waxman Amendments to the Federal Food, Drug and Cosmetic Act. He represents pharmaceutical companies in all aspects of federal intellectual property litigation, including pre-litigation activities, Paragraph IV Certifications, filing, fact and expert discovery, claim construction, motion practice, pre-trial, trial and post-trial phases.
News, Events, Notable Matters, and More
Showing Results for
Please understand that your communications with Locke Lord LLP through this website do not constitute or create an attorney-client relationship with Locke Lord LLP. Any information you send to Locke Lord LLP through this website is on a non-confidential and non-privileged basis. Therefore, do not send or include any information in your email that you consider to be confidential or privileged.